Topic: genetic sequencing
After fielding multiple takeover offers over the past month, Qiagen has instead decided to go it alone—and investors are less than pleased.
Illumina and Qiagen signed on to a long-term diagnostics partnership—with the latter opting to develop kits for the sequencing giant’s hardware.
FierceMedTech Fierce 15 winner 10x Genomics announced its plans for a $100 million IPO, on the Nasdaq using the symbol TXG.
10x Genomics is making moves into the emerging field of tissue genomics by buying Spatial Transcriptomics and its location-based mRNA analysis tools.
NeoGenomics has moved to acquire clinical oncology laboratory Genoptix for $125 million in cash plus 1 million shares of stock.
IBM and Illumina have joined an initiative to enable personalized leukemia treatment strategies.